Onderneming Xenetic Biosciences Inc Other OTC
Aandelen
US9840151073
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cell-based Therapeutics
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +48,80% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +48,80% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 11-07-16 | |
James F. Parslow
DFI | Director of Finance/CFO | 59 | 03-04-17 |
Curtis Lockshin
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-03-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 11-07-16 | |
Moshe Mizrahy
BRD | Director/Board Member | 71 | - |
Adam Logal
CHM | Chairman | 46 | 14-08-17 |
Director/Board Member | 56 | 01-01-04 | |
Roger Kornberg
BRD | Director/Board Member | 77 | 29-02-16 |
Director/Board Member | 72 | 23-01-14 | |
Director/Board Member | 54 | 19-07-19 | |
Director/Board Member | 68 | 14-08-17 | |
Director/Board Member | 55 | 25-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 804 394 | 0 | 0 | 80,81 % |
Aandeel B | 1 | 1 543 385 | 1 247 242 ( 80,81 %) | 2 701 ( 0,1750 %) | |
Aandeel C | 0 | 970 000 | 0 | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,52% | 113 mld. | |
+11,38% | 106 mld. | |
+0,93% | 22,27 mld. | |
-12,64% | 22,22 mld. | |
-4,69% | 19,43 mld. | |
-37,85% | 17,87 mld. | |
-8,58% | 17,24 mld. | |
+7,77% | 14,29 mld. | |
+37,41% | 12,52 mld. |
- Beurs
- Aandelen
- Koers XBIO
- Koers
- Onderneming Xenetic Biosciences Inc